lobbying_activities: 2507137

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2507137	c91fc14d-5ada-445c-8190-c8e1b856018c	Q3	KOUNTOUPES DENHAM CARR & REID, LLC	320918	CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION)	2020	third_quarter	PHA	Issues related to drug pricing in the pharmaceutical supply chain. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Issues related to the implementation of PL 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including Medicare and Medicaid provisions. Issues related to H.R. 6800, the Heroes Act. Issues related to proposals that would address drug shortages and national stockpile issues.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2020-10-13T17:38:01.273000-04:00